These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10471064)

  • 21. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro.
    Rossini A; Lima SS; Rapozo DC; Faria M; Albano RM; Pinto LF
    Braz J Med Biol Res; 2006 Feb; 39(2):195-201. PubMed ID: 16470306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.
    Ariyoshi N; Takahashi Y; Miyamoto M; Umetsu Y; Daigo S; Tateishi T; Kobayashi S; Mizorogi Y; Loriot MA; Stücker I; Beaune P; Kinoshita M; Kamataki T
    Pharmacogenetics; 2000 Nov; 10(8):687-93. PubMed ID: 11186131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a genotype previously designated as CYP2A6 D-type: CYP2A6*4B, another entire gene deletion allele of the CYP2A6 gene in Japanese.
    Ariyoshi N; Sekine H; Saito K; Kamataki T
    Pharmacogenetics; 2002 Aug; 12(6):501-4. PubMed ID: 12172220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
    Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles.
    Xu C; Rao YS; Xu B; Hoffmann E; Jones J; Sellers EM; Tyndale RF
    Biochem Biophys Res Commun; 2002 Jan; 290(1):318-24. PubMed ID: 11779172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population.
    Zhang X; Amemo K; Ameno S; Iwahashi K; Kinoshita H; Kubota T; Mostofa J; Ijiri I
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Oct; 36(5):486-90. PubMed ID: 11725533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females.
    Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T
    Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP.
    Kitagawa K; Kunugita N; Katoh T; Yang M; Kawamoto T
    Biochem Biophys Res Commun; 1999 Aug; 262(1):146-51. PubMed ID: 10448083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.
    Oscarson M
    Drug Metab Dispos; 2001 Feb; 29(2):91-5. PubMed ID: 11159795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase.
    Oscarson M; Gullstén H; Rautio A; Bernal ML; Sinues B; Dahl ML; Stengård JH; Pelkonen O; Raunio H; Ingelman-Sundberg M
    FEBS Lett; 1998 Nov; 438(3):201-5. PubMed ID: 9827545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of the CYP2A6*12 hybrid allele by Pyrosequencing technology.
    Koontz DA; Huckins JJ; Spencer A; Gallagher ML
    BMC Med Genet; 2009 Aug; 10():80. PubMed ID: 19703308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism of CYP2A6 in relation to cancer.
    Kamataki T; Nunoya K; Sakai Y; Kushida H; Fujita K
    Mutat Res; 1999 Jul; 428(1-2):125-30. PubMed ID: 10517986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2A6 polymorphism reveals differences in Japan and the existence of a specific variant in Ovambo and Turk populations.
    Takeshita H; Hieda Y; Fujihara J; Xue Y; Nakagami N; Takayama K; Imamura S; Kataoka K
    Hum Biol; 2006 Apr; 78(2):235-42. PubMed ID: 17036930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.
    Nunoya KI; Yokoi T; Kimura K; Kainuma T; Satoh K; Kinoshita M; Kamataki T
    J Pharmacol Exp Ther; 1999 Apr; 289(1):437-42. PubMed ID: 10087035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity.
    Kitagawa K; Kunugita N; Kitagawa M; Kawamoto T
    J Biol Chem; 2001 May; 276(21):17830-5. PubMed ID: 11278503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.
    Mochizuki J; Murakami S; Sanjo A; Takagi I; Akizuki S; Ohnishi A
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1191-7. PubMed ID: 16048566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct genotyping of Cytochrome P450 2A6 whole gene deletion from human blood samples by the SmartAmp method.
    Azuma K; Lezhava A; Shimizu M; Kimura Y; Ishizu Y; Ishikawa T; Kamataki T; Hayashizaki Y; Yamazaki H
    Clin Chim Acta; 2011 Jun; 412(13-14):1249-51. PubMed ID: 21420395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
    Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
    Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method.
    Mwenifumbo JC; Myers MG; Wall TL; Lin SK; Sellers EM; Tyndale RF
    Pharmacogenet Genomics; 2005 Mar; 15(3):189-92. PubMed ID: 15861044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.